SuperworthOpus Genetics market cap IRD
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $288.7M
- Highest close in our data
- $502.5M
- Sep 2026
Opus Genetics is worth $288.7M at the close on Oct 23, 2026, at $3.47 a share.
That is up 142% over the last year.
Its highest close in our data was $502.5M in Sep 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $288.7M | $133.1M | $502.5M | +107% |
| 2025 | $139.3M | $29.5M | $162.8M | +274% |
| 2024 | $37.3M | $29.3M | $37.3M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Opus Genetics' size, closest first, today.
| Company | Market cap |
|---|---|
| IRDOpus Genetics | $288.7M |
| NATRNatures Sunshine Products | $213.8M |
| ARVNArvinas | $477.3M |
| PBYIPuma Biotechnology | $568.9M |
| IRWDIronwood Pharmaceuticals | $571.7M |
| ZVRAZevra Therapeutics | $582.6M |
| CRMDCorMedix | $611.9M |
| COLLCollegium Pharmaceutical | $747.5M |
| ABUSArbutus Biopharma | $831M |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| LFVNLifevantage | $73.4M |
| Peer median | $577.1M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Opus Genetics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.